Literature DB >> 35617651

Robust Hepatitis A Vaccination Response Within the United States Veterans Health Administration in the Wake of State Outbreaks.

Andrew M Moon1, Joleen A Borgerding1, Ronald G Hauser1, Elliott Lowy1, Maggie Chartier1, Marissa M Maier1, Timothy Morgan1, Adam Ruege1, Jillian Weber1, Lauren A Beste1.   

Abstract

We assessed hepatitis A (HepA) vaccine receipt among susceptible individuals in outbreak and matched nonoutbreak states. Difference-in-differences models and multivariable logistic regression were used to compare HepA vaccination rates in these states. In the postoutbreak year, there was a 112% increase in HepA vaccinations in outbreak states versus a 6% decrease in nonoutbreak states. Differences persisted in our multivariable model (adjusted odds ratio = 2.53; 95% confidence interval = 2.45, 2.61). HepA vaccination rates increased dramatically in outbreak states, but many individuals susceptible to hepatitis A virus remain unvaccinated. (Am J Public Health. 2022;112(7):990-994. https://doi.org/10.2105/AJPH.2022.306845).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35617651      PMCID: PMC9222460          DOI: 10.2105/AJPH.2022.306845

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   11.561


  12 in total

1.  Influenza and pneumococcal vaccination of adults aged > or = 65: racial/ethnic differences.

Authors:  James A Singleton; Tammy A Santibanez; Pascale M Wortley
Journal:  Am J Prev Med       Date:  2005-12       Impact factor: 5.043

Review 2.  Immunization to protect the US Armed Forces: heritage, current practice, and prospects.

Authors:  John D Grabenstein; Phillip R Pittman; John T Greenwood; Renata J M Engler
Journal:  Epidemiol Rev       Date:  2006-06-08       Impact factor: 6.222

3.  Hepatitis A Virus Prevention and Vaccination Within and Outside the Veterans Health Administration in Light of Recent Outbreaks.

Authors:  Andrew M Moon; Elliott Lowy; Marissa M Maier; Maggie Chartier; Timothy R Morgan; Lori Hoffman-Högg; Lauren A Beste
Journal:  Fed Pract       Date:  2018-03

4.  Designing Difference in Difference Studies: Best Practices for Public Health Policy Research.

Authors:  Coady Wing; Kosali Simon; Ricardo A Bello-Gomez
Journal:  Annu Rev Public Health       Date:  2018-01-12       Impact factor: 21.981

5.  Clinical manifestations of hepatitis A: recent experience in a community teaching hospital.

Authors:  M J Tong; N S el-Farra; M I Grew
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

6.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

7.  Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016.

Authors:  Shaoman Yin; Laurie Barker; Kathleen N Ly; Greta Kilmer; Monique A Foster; Jan Drobeniuc; Ruth B Jiles
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

8.  Immunogenicity of the hepatitis A vaccine 20 years after infant immunization.

Authors:  E Mosites; S Seeman; S Negus; C Homan; J Morris; N P Nelson; P R Spradling; M Bruce; B McMahon
Journal:  Vaccine       Date:  2020-06-10       Impact factor: 3.641

9.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03

10.  Increase in Hepatitis A Virus Infections - United States, 2013-2018.

Authors:  Monique A Foster; Megan G Hofmeister; Benjamin A Kupronis; Yulin Lin; Guo-Liang Xia; Shaoman Yin; Eyasu Teshale
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-05-10       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.